INSIDER · CIK 1682019
Kulkarni Samarth
Chief Executive Officer, Director at CRISPR Therapeutics AG (CRSP)
↗4 Form 4 rows in the window
Covers original filings from Jul 31, 2026 to Oct 28, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$2.6MSold on the market
1Companies
Oct 20, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202617:35 | Oct 19, 2026 | CRSPCRISPR Therapeutics AG | Chief Executive Officer, Director | S · Sell | $49.78 | −47,837 | 311,899 | -13% | −$2.4M | ||
| Oct 20, 202617:35 | Oct 16, 2026 | CRSPCRISPR Therapeutics AG | Chief Executive Officer, Director | M · Exercise | — | +100,000 | 359,736 | +39% | — | ||
| Oct 15, 202617:35 | Oct 14, 2026 | CRSPCRISPR Therapeutics AG | Chief Executive Officer, Director | S · Sell | $49.26 | −4,098 | 259,736 | -2% | −$202K | ||
| Oct 15, 202617:35 | Oct 13, 2026 | CRSPCRISPR Therapeutics AG | Chief Executive Officer, Director | M · Exercise | — | +8,333 | 263,834 | +3% | — |